Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes
Clinical trial NCT01512979 · COMPLETED
Trial details
- NCT number
- NCT01512979
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2013-04-01
- Enrollment
- 316
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.